HSCS
Price
$3.38
Change
-$0.12 (-3.43%)
Updated
Aug 15 closing price
Capitalization
7.59M
SERA
Price
$2.37
Change
+$0.12 (+5.33%)
Updated
Aug 18, 12:41 PM (EDT)
Capitalization
85.64M
79 days until earnings call
Interact to see
Advertisement

HSCS vs SERA

Header iconHSCS vs SERA Comparison
Open Charts HSCS vs SERABanner chart's image
HeartSciences
Price$3.38
Change-$0.12 (-3.43%)
Volume$84.23K
Capitalization7.59M
Sera Prognostics
Price$2.37
Change+$0.12 (+5.33%)
Volume$100
Capitalization85.64M
HSCS vs SERA Comparison Chart in %
Loading...
HSCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HSCS vs. SERA commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSCS is a Hold and SERA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (HSCS: $3.38 vs. SERA: $2.25)
Brand notoriety: HSCS and SERA are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: HSCS: 63% vs. SERA: 22%
Market capitalization -- HSCS: $7.59M vs. SERA: $85.64M
HSCS [@Medical/Nursing Services] is valued at $7.59M. SERA’s [@Medical/Nursing Services] market capitalization is $85.64M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $229.31B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSCS’s FA Score shows that 0 FA rating(s) are green whileSERA’s FA Score has 0 green FA rating(s).

  • HSCS’s FA Score: 0 green, 5 red.
  • SERA’s FA Score: 0 green, 5 red.
According to our system of comparison, HSCS is a better buy in the long-term than SERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSCS’s TA Score shows that 4 TA indicator(s) are bullish while SERA’s TA Score has 3 bullish TA indicator(s).

  • HSCS’s TA Score: 4 bullish, 5 bearish.
  • SERA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HSCS is a better buy in the short-term than SERA.

Price Growth

HSCS (@Medical/Nursing Services) experienced а -5.85% price change this week, while SERA (@Medical/Nursing Services) price change was -9.27% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.79%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was +3.54%.

Reported Earning Dates

SERA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical/Nursing Services (+2.79% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SERA($85.6M) has a higher market cap than HSCS($7.59M). HSCS YTD gains are higher at: -11.518 vs. SERA (-72.359). HSCS has higher annual earnings (EBITDA): -8.05M vs. SERA (-32.13M). SERA has more cash in the bank: 46.2M vs. HSCS (2.6M). SERA has less debt than HSCS: SERA (568K) vs HSCS (2.99M). SERA has higher revenues than HSCS: SERA (115K) vs HSCS (0).
HSCSSERAHSCS / SERA
Capitalization7.59M85.6M9%
EBITDA-8.05M-32.13M25%
Gain YTD-11.518-72.35916%
P/E Ratio0.55N/A-
Revenue0115K-
Total Cash2.6M46.2M6%
Total Debt2.99M568K526%
TECHNICAL ANALYSIS
Technical Analysis
HSCSSERA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 26 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
89%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HSCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PNCKF0.390.01
+1.55%
Galleon Gold Corp.
BKNIY15.510.08
+0.52%
Bankinter, S.A.
APNHY6.36N/A
N/A
Aspen Pharmacare Holdings plc
BHHOF0.21N/A
N/A
Boohoo Group Plc
RMTG0.05-0.02
-25.93%
Regenerative Medical Technology Group Inc.

HSCS and

Correlation & Price change

A.I.dvisor tells us that HSCS and IQV have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSCS and IQV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSCS
1D Price
Change %
HSCS100%
-3.43%
IQV - HSCS
22%
Poorly correlated
+0.89%
CERS - HSCS
22%
Poorly correlated
-2.36%
SERA - HSCS
21%
Poorly correlated
N/A
MBOT - HSCS
21%
Poorly correlated
-1.28%
MTD - HSCS
21%
Poorly correlated
-0.10%
More